# K020963: Taperloc Porous Femoral Stem & HA Taperloc Porous Lateralized Femoral Stem

- Pathway: 510(k) (Special)
- Applicant: Biomet Orthopedics, Inc.
- Decided: Apr 16, 2002 after 22 days
- Product code: MEH (Prosthesis, Hip, Semi-Constrained, Uncemented, Metal / Polymer, Non-Porous, Calcium Phosphate)
- Device class: 2
- Regulation: 21 CFR 888.3353
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K921301 (1994). 1 ancestor in all.
234 later devices descend from it; 2 cite it directly.
1 of 236 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K921301: Taperloc Femoral Stem and Universal Acetabular Com, Biomet, Inc. (1994) Summary page 1.

## Most influential descendants
- K043079: Bicontact Hip System with U-Cap (2004), 166 descendants of its own
- K093472: Trinity Acetabular System (2010), 117 descendants of its own
- K110087: Corin Trinity Acetbular System with Hxlpe Liners (2011), 109 descendants of its own
- K060437: Excia Total Hip System with U-Cap (2006), 90 descendants of its own
- K032726: Zimmer M/L Taper Hip Prosthesis, 7711 Series (2003), 84 descendants of its own

## Indications for use
The HA Taperloc® Porous Femoral Stem & HA Taperloc® Porous Lateralized Femoral Stem are indicated for use for 1) Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis; 2) Rheumatoid arthritis; 3) Correction of functional deformity; 4) Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques; and 5) Revision procedures where other treatments or devices have failed.

Source page: https://510kreport.com/device/K020963
Methodology: https://510kreport.com/methodology